In non-anemic pregnant women, a weekly regimen is an effective alternative to a daily regimen for antenatal oral iron and folate supplementation for preventing anemia and iron deficiency during the third trimester.
One of the challenges faced by clinicians is when laboratory investigations do not match the clinical impression of a patient's condition, and when the investigation is repeated, significant intra
Interpret proteinuria with full clinical picture, symptoms, signs, and other investigations for preeclampsia. Use an automated reagent-strip/ dipstick screening wherever possible. (when dipstick screening is positive (1+ or more), use protein: creatinine ratio (UPCR) for quantification). When using UPCR to quantify, use 30 mg/mmol as the threshold for significant proteinuria. Consider the need for intravenous magnesium sulfate in women with preeclampsia. Use the collaborative eclampsia trial regimen for administration of magnesium sulfate. Carry out an ultrasound for fetal growth and amniotic fluid volume assessment and umbilical artery doppler velocimetry at diagnosis and if normal repeat every 2 to 4 weeks, if clinically indicated. If a woman has taken methyldopa to treat chronic hypertension during pregnancy, stop within 2 days after the birth and change to an alternative antihypertensive treatment. In women with chronic hypertension who have given birth: aim to keep blood pressure lower than 140/90 mmHg and continue antihypertensive treatment. Offer a review of antihypertensives 2 weeks after the birth. Offer a medical review 6 weeks after the birth.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.